These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1311 related items for PubMed ID: 17471463

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Epigenetic inactivation of the tumor suppressor gene RIZ1 in hepatocellular carcinoma involves both DNA methylation and histone modifications.
    Zhang C, Li H, Wang Y, Liu W, Zhang Q, Zhang T, Zhang X, Han B, Zhou G.
    J Hepatol; 2010 Nov; 53(5):889-95. PubMed ID: 20675009
    [Abstract] [Full Text] [Related]

  • 3. Transcriptional silencing of the DLC-1 tumor suppressor gene by epigenetic mechanism in gastric cancer cells.
    Kim TY, Jong HS, Song SH, Dimtchev A, Jeong SJ, Lee JW, Kim TY, Kim NK, Jung M, Bang YJ.
    Oncogene; 2003 Jun 19; 22(25):3943-51. PubMed ID: 12813468
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Differential regulation of the alcohol dehydrogenase 1B (ADH1B) and ADH1C genes by DNA methylation and histone deacetylation.
    Dannenberg LO, Chen HJ, Tian H, Edenberg HJ.
    Alcohol Clin Exp Res; 2006 Jun 19; 30(6):928-37. PubMed ID: 16737450
    [Abstract] [Full Text] [Related]

  • 6. Tissue factor pathway inhibitor-2 as a frequently silenced tumor suppressor gene in hepatocellular carcinoma.
    Wong CM, Ng YL, Lee JM, Wong CC, Cheung OF, Chan CY, Tung EK, Ching YP, Ng IO.
    Hepatology; 2007 May 19; 45(5):1129-38. PubMed ID: 17464989
    [Abstract] [Full Text] [Related]

  • 7. Hypoxic silencing of tumor suppressor RUNX3 by histone modification in gastric cancer cells.
    Lee SH, Kim J, Kim WH, Lee YM.
    Oncogene; 2009 Jan 15; 28(2):184-94. PubMed ID: 18850007
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Promoter histone H3 lysine 9 di-methylation is associated with DNA methylation and aberrant expression of p16 in gastric cancer cells.
    Meng CF, Zhu XJ, Peng G, Dai DQ.
    Oncol Rep; 2009 Nov 15; 22(5):1221-7. PubMed ID: 19787243
    [Abstract] [Full Text] [Related]

  • 12. Heparanase expression is associated with histone modifications in glioblastoma.
    Hong X, Nelson K, Lemke N, Kalkanis SN.
    Int J Oncol; 2012 Feb 15; 40(2):494-500. PubMed ID: 22001963
    [Abstract] [Full Text] [Related]

  • 13. [Study of RASSF1A expression and promoter demethylation in Hep-2 cell line].
    Yang J, Ji W, Qu Y, He L, Zhao X.
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Jan 15; 25(2):64-6. PubMed ID: 21473137
    [Abstract] [Full Text] [Related]

  • 14. Synergistic activation of functional estrogen receptor (ER)-alpha by DNA methyltransferase and histone deacetylase inhibition in human ER-alpha-negative breast cancer cells.
    Yang X, Phillips DL, Ferguson AT, Nelson WG, Herman JG, Davidson NE.
    Cancer Res; 2001 Oct 01; 61(19):7025-9. PubMed ID: 11585728
    [Abstract] [Full Text] [Related]

  • 15. Selective association of the methyl-CpG binding protein MBD2 with the silent p14/p16 locus in human neoplasia.
    Magdinier F, Wolffe AP.
    Proc Natl Acad Sci U S A; 2001 Apr 24; 98(9):4990-5. PubMed ID: 11309512
    [Abstract] [Full Text] [Related]

  • 16. Genome-wide transcriptional response to 5-aza-2'-deoxycytidine and trichostatin a in multiple myeloma cells.
    Heller G, Schmidt WM, Ziegler B, Holzer S, Müllauer L, Bilban M, Zielinski CC, Drach J, Zöchbauer-Müller S.
    Cancer Res; 2008 Jan 01; 68(1):44-54. PubMed ID: 18172295
    [Abstract] [Full Text] [Related]

  • 17. [Effects of 5-Aza-2'-deoxycytidine and trichostatin A on DNA methylation and expression of hMLH1 in ovarian cancer cell line COC1/DDP].
    Meng CF, Dai DQ, Guo KJ.
    Ai Zheng; 2008 Dec 01; 27(12):1251-5. PubMed ID: 19079988
    [Abstract] [Full Text] [Related]

  • 18. Genetic and epigenetic inactivation of T-cadherin in human hepatocellular carcinoma cells.
    Chan DW, Lee JM, Chan PC, Ng IO.
    Int J Cancer; 2008 Sep 01; 123(5):1043-52. PubMed ID: 18553387
    [Abstract] [Full Text] [Related]

  • 19. Histone modification in the TGFbetaRII gene promoter and its significance for responsiveness to HDAC inhibitor in lung cancer cell lines.
    Osada H, Tatematsu Y, Sugito N, Horio Y, Takahashi T.
    Mol Carcinog; 2005 Dec 01; 44(4):233-41. PubMed ID: 16163707
    [Abstract] [Full Text] [Related]

  • 20. The essential role of histone H3 Lys9 di-methylation and MeCP2 binding in MGMT silencing with poor DNA methylation of the promoter CpG island.
    Zhao W, Soejima H, Higashimoto K, Nakagawachi T, Urano T, Kudo S, Matsukura S, Matsuo S, Joh K, Mukai T.
    J Biochem; 2005 Mar 01; 137(3):431-40. PubMed ID: 15809347
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 66.